Physician

Anil Rajendra, M.D.

According to 2025 Medicare claims, Anil Rajendra, M.D. (NPI: 1376740589) practices cardiac electrophysiology in the Auburn-Opelika, AL market, with the plurality of this provider's patient population coming from Lee, AL. This provider's primary affiliated billing organization is AFFINITY CARDIOVASCULAR SPECIALISTS LLC (NPI: 1215305925; TIN: 383976603) and primary practice location at 35243-3326. Rajendra is affiliated with the CHSPSC ACO 8, LLC (ACO ID: A3715) and Rancho Health Management, LLC (ACO ID: D0015), participating under both the MSSP and REACH models.

Rajendra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 606 traditional Medicare patients, billed 2,264 HCPCS/CPT codes, and received $266,804 in Medicare payments. The top billing code was 93656 (Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation). Part D data shows 1,611 prescription claims across 410 beneficiaries totaling $548,879 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 274 records totaling $551,699. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $136,444 to $266,804. Similarly, Part D prescription costs have moved sharply higher in recent years, from $30,156 to $548,879. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	349	1,722	$136,444
2016	521	2,604	$260,068
2017	452	2,589	$217,797
2018	477	2,990	$221,271
2019	498	3,093	$227,323
2020	613	3,335	$255,713
2021	635	3,770	$298,407
2022	646	3,652	$294,805
2023	655	3,214	$267,533
2024	606	2,264	$266,804

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	59	162	$30,156
2016	106	356	$61,378
2017	130	423	$73,528
2018	177	743	$157,071
2019	185	788	$169,599
2020	222	937	$198,484
2021	305	1,456	$324,777
2022	339	1,533	$415,032
2023	337	1,553	$536,650
2024	410	1,611	$548,879

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93656	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation	130	134	$642
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	122	133	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	123	129	$59
93623	Programming of heart rhythm stimulation after drug infusion	133	137	$47
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	211	244	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	434	17,568	$334,849
Multaq	Dronedarone Hcl	94	3,510	$90,334
Entresto	Sacubitril/Valsartan	59	2,370	$47,942
Xarelto	Rivaroxaban	62	2,490	$46,109
Flecainide Acetate	Flecainide Acetate	151	9,188	$9,068

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	182	$150,070	Medical Device Business Services, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	92	$401,629	Biosense Webster, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anil Rajendra, M.D.?

Tedicare shows public-source Medicare data for Anil Rajendra, M.D. (NPI 1376740589), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anil Rajendra, M.D. have ACO affiliation data?

Anil Rajendra, M.D. is shown with ACO affiliation data for CHSPSC ACO 8, LLC (MSSP, ACO ID A3715) and Rancho Health Management, LLC (REACH, ACO ID D0015).

What billing organization is linked to Anil Rajendra, M.D.?

Anil Rajendra, M.D. is linked to AFFINITY CARDIOVASCULAR SPECIALISTS LLC (billing NPI 1215305925) in the available physician profile data.

Does Anil Rajendra, M.D. have Open Payments data?

Anil Rajendra, M.D. has 274 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.